COMBINATION THERAPY FOR THE TREATMENT OF MIGRAINE

Disclosed is a pharmaceutical composition for treating migraine in a mammal, including a human, which comprises a 5HT1, receptor agonist in combination with caffeine and a cyclooxygenase-2 (COX-2) inhibitor. Examples of the 5HT1 receptor agonist are eletriptan, rizatriptan, naratriptan, sumatriptan,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HARRISON, WILMA MARCIA, SANDS, GEORGE HARRY
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is a pharmaceutical composition for treating migraine in a mammal, including a human, which comprises a 5HT1, receptor agonist in combination with caffeine and a cyclooxygenase-2 (COX-2) inhibitor. Examples of the 5HT1 receptor agonist are eletriptan, rizatriptan, naratriptan, sumatriptan, zolmitriptan and ergotamine.